Authors
Loading...
Computational modeling study reveals substantial variability in CYP2D6 enzyme activity across populations, indicating the necessity of evaluating metabolic distributions in xenobiotic risk assessment.
Neafsey et al. (2009) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: